Schedule 13D ownership disclosure
RENEO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 75974E103
Event date: 2023-05-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-139466
- Form type
- SC 13D
- Filer
- Carlyle Group Inc.
- CIK
- CIK 1527166
- Filed
- May 09, 2023
- Reporting period
- May 02, 2023
- Description
- Schedule 13D beneficial ownership